Lynparza 50 mg hard capsules * Show product notice

  • Company:

    AstraZeneca Pharmaceuticals (Ireland) DAC
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)
  • Active Ingredient(s):

    *Additional information is available within the SPC or upon request to the company

  • What is a Patient Information leaflet and why is it useful?

    A Patient Information Leaflet (PIL) is the leaflet containing information on taking or using a medicine for patients, included with medicine packaging. It is written by pharmaceutical companies as a patient version of the Summary of Product Characteristics (SPC). Changes to the PIL after your medicine was packed may mean the version on may differ from the version found with your medicine.

  • 20210211 Package Leaflet IE MT Lynparza Capsules 50mg SOLO-2 OS ONC 21 0006

    Last updated: 15/02/21

Product Notice

Discontinued Strength Notice

Reminder: Lynparza 50 mg Hard Capsules have been discontinued. It is expected that stock will be depleted by December 2021.